EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

RORα, a potential tumor suppressor and therapeutic target of breast cancer


International Journal of Molecular Sciences 13(12): 15755-15766
RORα, a potential tumor suppressor and therapeutic target of breast cancer
The function of the nuclear receptor (NR) in breast cancer progression has been investigated for decades. The majority of the nuclear receptors have well characterized natural ligands, but a few of them are orphan receptors for which no ligand has been identified. RORα, one member of the retinoid orphan nuclear receptor (ROR) subfamily of orphan receptors, regulates various cellular and pathological activities. RORα is commonly down-regulated and/or hypoactivated in breast cancer compared to normal mammary tissue. Expression of RORα suppresses malignant phenotypes in breast cancer cells, in vitro and in vivo. Activity of RORα can be categorized into the canonical and non-canonical nuclear receptor pathways, which in turn regulate various breast cancer cellular function, including cell proliferation, apoptosis and invasion. This information suggests that RORα is a potent tumor suppressor and a potential therapeutic target for breast cancer.


Accession: 055338265

PMID: 23443091

DOI: 10.3390/ijms131215755



Related references

Oncogenes and tumor suppressor genes in breast cancer: potential diagnostic and therapeutic applications. Oncologist 9(4): 361-377, 2004

PML: An emerging tumor suppressor and a target with therapeutic potential. Cancer Therapy 7(A): 219-226, 2009

Small interfering RNA library screen identified polo-like kinase-1 (PLK1) as a potential therapeutic target for breast cancer that uniquely eliminates tumor-initiating cells. Breast Cancer Research 14(1): R22-R22, 2013

Tumor suppressor p53 gene: a potential target for cancer therapy?. Bulletin du Cancer 84(7): 753-756, 1997

The p53 tumor suppressor: a master regulator of diverse cellular processes and therapeutic target in cancer. Biochemical and Biophysical Research Communications 396(1): 85-89, 2010

Transcriptional regulation of the p53 tumor suppressor gene: a potential target for cancer therapeutics?. Recent Patents on Dna & Gene Sequences 1(3): 176-185, 2009

Epigenetic inactivation of the candidate tumor suppressor gene ASC/TMS1 in human renal cell carcinoma and its role as a potential therapeutic target. Oncotarget 6(26): 22706-22723, 2016

Tumour suppressor HLJ1: A potential diagnostic, preventive and therapeutic target in non-small cell lung cancer. World Journal of Clinical Oncology 5(5): 865-873, 2014

The retinoblastoma tumor suppressor modifies the therapeutic response of breast cancer. Journal of Clinical Investigation 117(1): 218-228, 2006

The retinoblastoma tumor suppressor modifies the therapeutic response of breast cancer. Journal of Clinical Investigation 117(1): 218-228, 2007